Healthcare companies by risk reading
Healthcare companies by risk reading: 1,695 companies ranked by a composite risk reading built from filed statements -- leverage, cash conversion, operating pressure, customer and supplier concentration and competitive position. Recomputed 21 October 2026.
Composite readings for 14,899 companies, recomputed 21 October 2026. A company appears here once at least three weighted categories cleared their inputs; the rest carry per-mechanism readings without a headline.
| Company | Reading | Band | Sector | Country | Coverage | Market cap |
|---|---|---|---|---|---|---|
| NeuroOne Medical Technologies Corp NMTC | 47 | Elevated | Healthcare | United States | 6 / 6 | $9M |
| MARINOMED BIOTECH AG INH. 93Z | 38 | Normal | Healthcare | Austria | 5 / 6 | $8M |
| Nanologica AB NICA | 51 | Elevated | Healthcare | Sweden | 4 / 6 | $8M |
| PREDICT PRE.MI | 31 | Normal | Healthcare | Italy | 5 / 6 | $8M |
| Bolt Biotherapeutics Inc BOLT | 52 | Elevated | Healthcare | United States | 5 / 6 | $8M |
| American Shared Hospital Services AMS | 45 | Elevated | Healthcare | United States | 5 / 6 | $8M |
| Terminalcare Support Institute Inc. 7362.T | 37 | Normal | Healthcare | Japan | 5 / 6 | $8M |
| Boule Diagnostics AB BOUL | 50 | Elevated | Healthcare | Sweden | 4 / 6 | $8M |
| Karyopharm Therapeutics Inc KPTI | 42 | Elevated | Healthcare | United States | 6 / 6 | $8M |
| OptiBiotix Health Plc OPTI | 54 | Elevated | Healthcare | United Kingdom | 3 / 6 | $8M |
| Ensysce Biosciences Inc ENSC | 54 | Elevated | Healthcare | United States | 5 / 6 | $8M |
| Pila Pharma AB PILA | 75 | Stretched | Healthcare | Sweden | 3 / 6 | $8M |
| PhoenixBio Co., Ltd. 6190.T | 42 | Elevated | Healthcare | Japan | 5 / 6 | $8M |
| Biomerica Inc BMRA | 65 | Stretched | Healthcare | United States | 6 / 6 | $8M |
| Conneqt Health Limited CQT | 33 | Normal | Healthcare | Australia | 4 / 6 | $8M |
| DataMEDS AI, Inc. MEDS | 91 | Acute | Healthcare | United States | 5 / 6 | $8M |
| Universal Health International Group Holding Limited 2211.HK | 56 | Elevated | Healthcare | China | 4 / 6 | $8M |
| Epsilon Healthcare Ltd EPN | 28 | Normal | Healthcare | Australia | 4 / 6 | $8M |
| OPTIBIOTIX HLTH PLC LS-02 OB3 | 55 | Elevated | Healthcare | United Kingdom | 3 / 6 | $8M |
| Wellgistics Health Inc WGRX | 96 | Acute | Healthcare | United States | 3 / 6 | $8M |
| ARCTIC BIOSCIENCE ABS.OL | 39 | Normal | Healthcare | Norway | 5 / 6 | $8M |
| Qianhai Health Holdings Limited 0911.HK | 29 | Normal | Healthcare | Hong Kong | 5 / 6 | $8M |
| OXFORD BIODYNAMICS LS-01 LMQ | 58 | Elevated | Healthcare | United Kingdom | 4 / 6 | $8M |
| Alaunos Therapeutics Inc TCRT | 81 | Acute | Healthcare | United States | 4 / 6 | $7M |
| Bellevue Life Sciences Acquisition Corp OSRH | 91 | Acute | Healthcare | United States | 5 / 6 | $7M |
| baby calendar Inc. 7363.T | 12 | Contained | Healthcare | Japan | 5 / 6 | $7M |
| InMed Pharmaceuticals Inc INM | 41 | Elevated | Healthcare | Canada | 3 / 6 | $7M |
| Allurion Technologies Inc ALUR | 58 | Elevated | Healthcare | United States | 4 / 6 | $7M |
| Senti Biosciences Inc SNTI | 84 | Acute | Healthcare | United States | 4 / 6 | $7M |
| Medicskin Holdings Limited 8307.HK | 24 | Normal | Healthcare | Hong Kong | 5 / 6 | $7M |
| Oncodesign Precision Medicine ALOPM | 40 | Elevated | Healthcare | France | 3 / 6 | $7M |
| ONCODESIGN PM ALOPM.PA | 40 | Elevated | Healthcare | France | 3 / 6 | $7M |
| Cann Group Limited CAN.AX | 73 | Stretched | Healthcare | Australia | 4 / 6 | $7M |
| SynBiotic SE SBX | 34 | Normal | Healthcare | Germany | 5 / 6 | $7M |
| Arctic Bioscience AS ABS | 31 | Normal | Healthcare | Norway | 5 / 6 | $7M |
| Verici Dx Plc VRCI | 59 | Elevated | Healthcare | United Kingdom | 4 / 6 | $7M |
| ECS Botanics Holdings Ltd ECS | 18 | Contained | Healthcare | Australia | 4 / 6 | $7M |
| Careteq Ltd CTQ | 30 | Normal | Healthcare | Australia | 3 / 6 | $7M |
| VERICI DX PLC LS-001 63V | 55 | Elevated | Healthcare | United Kingdom | 3 / 6 | $7M |
| Firebrick Pharma Limited FRE.AX | 36 | Normal | Healthcare | Australia | 3 / 6 | $7M |
| Media Lab SpA MLLAB | 27 | Normal | Healthcare | Italy | 5 / 6 | $7M |
| CurveBeam AI Limited CVB.AX | 89 | Acute | Healthcare | United States | 3 / 6 | $7M |
| Nutex Investments PLC NUTEX | 72 | Stretched | Healthcare | Hungary | 4 / 6 | $7M |
| Prostatype Genomics AB PROGEN | 66 | Stretched | Healthcare | Sweden | 4 / 6 | $7M |
| Alligator Bioscience ATORX.ST | 60 | Stretched | Healthcare | Sweden | 3 / 6 | $7M |
| TruScreen Group Limited TRU.AX | 27 | Normal | Healthcare | New Zealand | 4 / 6 | $6M |
| Bio-Gate AG BIG.DE | 33 | Normal | Healthcare | Germany | 5 / 6 | $6M |
| New Ray Medicine International Holding Limited 6108.HK | 29 | Normal | Healthcare | China | 5 / 6 | $6M |
| Immuron Ltd IMRN | 21 | Normal | Healthcare | Australia | 3 / 6 | $6M |
| Adheris Health Limited AHE | 10 | Contained | Healthcare | United States | 4 / 6 | $6M |
| Traws Pharma Inc TRAW | 60 | Stretched | Healthcare | United States | 3 / 6 | $6M |
| CollPlant Biotechnologies Ltd New CLGN | 35 | Normal | Healthcare | Israel | 4 / 6 | $6M |
| XWELL Inc XWEL | 69 | Stretched | Healthcare | United States | 5 / 6 | $6M |
| Sonoma Pharmaceuticals Inc SNOA | 28 | Normal | Healthcare | United States | 6 / 6 | $6M |
| AMA Corp PLC ALAMA | 87 | Acute | Healthcare | France | 5 / 6 | $5M |
| Zhongchao Inc - Class A ZCMD | 47 | Elevated | Healthcare | China | 4 / 6 | $5M |
| Mangoceuticals Inc MGRX | 58 | Elevated | Healthcare | United States | 3 / 6 | $5M |
| SoftMedx Healthcare Limited 0648.HK | 13 | Contained | Healthcare | Hong Kong | 4 / 6 | $5M |
| Innovative Eyewear Inc LUCY | 54 | Elevated | Healthcare | United States | 4 / 6 | $5M |
| N4 Pharma PLC N4P | 47 | Elevated | Healthcare | United Kingdom | 3 / 6 | $5M |
| GENinCode Plc GENI.L | 54 | Elevated | Healthcare | United Kingdom | 5 / 6 | $5M |
| Cuprina Holdings (Cayman) Ltd - Class A CUPR | 74 | Stretched | Healthcare | Singapore | 4 / 6 | $5M |
| Plant Advanced Technologies SA ALPAT | 46 | Elevated | Healthcare | France | 4 / 6 | $5M |
| Cardio Diagnostics Holdings Inc CDIO | 59 | Elevated | Healthcare | United States | 5 / 6 | $5M |
| Femasys Inc FEMY | 39 | Normal | Healthcare | United States | 5 / 6 | $5M |
| Clearbridge Health Limited 1H3.SI | 61 | Stretched | Healthcare | Singapore | 5 / 6 | $5M |
| Alligator Bioscience AB ATORX | 60 | Stretched | Healthcare | Sweden | 3 / 6 | $5M |
| Scienture Holdings Inc SCNX | 72 | Stretched | Healthcare | United States | 3 / 6 | $5M |
| Evogene Ltd EVGN | 50 | Elevated | Healthcare | Israel | 5 / 6 | $5M |
| Surgical Innovations Group plc SUN.L | 46 | Elevated | Healthcare | United Kingdom | 5 / 6 | $5M |
| Prostatype Genomics PROGEN.ST | 65 | Stretched | Healthcare | Sweden | 5 / 6 | $5M |
| Cambridge Nutritional Sciences plc CNSL | 36 | Normal | Healthcare | United Kingdom | 5 / 6 | $5M |
| Creative Medical Technology Holdings Inc CELZ | 80 | Acute | Healthcare | United States | 3 / 6 | $5M |
| Intelligent Bio Solutions Inc INBS | 64 | Stretched | Healthcare | United States | 5 / 6 | $5M |
| Aclarion Inc ACON | 61 | Stretched | Healthcare | United States | 4 / 6 | $5M |
| Gelteq Ltd GELS | 75 | Stretched | Healthcare | Australia | 4 / 6 | $5M |
| Longeveron Inc - Class A LGVN | 74 | Stretched | Healthcare | United States | 5 / 6 | $5M |
| CASI Pharmaceuticals Inc CASI | 73 | Stretched | Healthcare | China | 4 / 6 | $5M |
| Xenetic Biosciences Inc XBIO | 20 | Normal | Healthcare | United States | 3 / 6 | $5M |
| Zelira Therapeutics Ltd ZLD | 85 | Acute | Healthcare | Australia | 4 / 6 | $5M |
| OMEGA DIAGNOST.GR. LS-04 RVKA | 34 | Normal | Healthcare | United Kingdom | 4 / 6 | $5M |
| Lexaria Bioscience Corp LEXX | 46 | Elevated | Healthcare | Canada | 4 / 6 | $4M |
| Futura Medical FUM | 78 | Stretched | Healthcare | United Kingdom | 3 / 6 | $4M |
| cbdMD Inc YCBD | 46 | Elevated | Healthcare | United States | 5 / 6 | $4M |
| Spineway SA ALSPW.PA | 24 | Normal | Healthcare | France | 4 / 6 | $4M |
| HITIQ Ltd HIQ | 74 | Stretched | Healthcare | Australia | 4 / 6 | $4M |
| Predilife ALPRE | 57 | Elevated | Healthcare | France | 5 / 6 | $4M |
| Feedback PLC FDBK | 71 | Stretched | Healthcare | United Kingdom | 4 / 6 | $4M |
| Sanai Health Industry Group Company Limited WUP0 | 57 | Elevated | Healthcare | Hong Kong | 4 / 6 | $4M |
| Icecure Medical Ltd ICCM | 46 | Elevated | Healthcare | Israel | 4 / 6 | $4M |
| Spineway ALSPW | 25 | Normal | Healthcare | France | 4 / 6 | $4M |
| MaxWin International Holdings Limited 8513.HK | 28 | Normal | Healthcare | Singapore | 5 / 6 | $3M |
| Monsenso AS MONSO | 45 | Elevated | Healthcare | Denmark | 5 / 6 | $3M |
| MediNet Group Limited 8161.HK | 33 | Normal | Healthcare | Hong Kong | 5 / 6 | $3M |
| Imaging Biometrics Ltd. IBAI.L | 21 | Normal | Healthcare | Jersey | 4 / 6 | $3M |
| Addex Therapeutics Ltd ADXN | 75 | Stretched | Healthcare | Switzerland | 4 / 6 | $3M |
| Co-Diagnostics, Inc. CODX | 72 | Stretched | Healthcare | United States | 5 / 6 | $3M |
| Acrux Limited ACR.AX | 51 | Elevated | Healthcare | Australia | 4 / 6 | $3M |
| BSF Enterprise Plc BSFA | 44 | Elevated | Healthcare | United Kingdom | 4 / 6 | $3M |
| Physiomics Plc PYC | 42 | Elevated | Healthcare | United Kingdom | 4 / 6 | $3M |
By sector
How the reading is built
Each company is scored on six mechanisms -- market expectation, operating pressure, cash conversion, leverage, concentration and competitive position -- from its own filed statements. A mechanism whose inputs do not clear its coverage floor is left unread rather than scored zero, and a reading built on thin coverage is pulled toward a neutral prior rather than claiming safety from what nobody looked at.
Descriptive, not advisory. These bands describe measured mechanisms; they are not investment advice, not a forecast, and not a statement about whether a share is worth owning.